This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock Get the Latest News and Ratings for BIOA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for (BIOA) and its competitors. Enter your email to sign up for newsletter Sign Up BIOA Analyst Ratings Over TimeTypeCurrent Forecast4/25/24 to 4/25/251 Month Ago3/26/24 to 3/26/253 Months Ago1/26/24 to 1/25/251 Year Ago4/26/23 to 4/25/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s) N/A Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s) N/A Hold3 Hold rating(s)3 Hold rating(s)2 Hold rating(s) N/A Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s) N/A Consensus Price Target$5.67$5.67$6.33N/AForecasted Upside34.28% Upside42.20% Upside17.39% UpsideN/AConsensus RatingReduceReduceReduceN/A BIOA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History BIOA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table (BIOA) Stock vs. The CompetitionType(BIOA)Medical CompaniesS&P 500Consensus Rating Score 1.75 2.82 2.54Consensus RatingReduceModerate BuyModerate BuyPredicted Upside34.28% Upside2,753.01% Upside21.42% UpsideNews Sentiment RatingNeutral NewsSee Recent BIOA NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/24/2025Citigroup2 of 5 starsS. SemenkowSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetNeutral ➝ Neutral$7.00 ➝ $5.00+12.36%3/21/2025William Blair1 of 5 starsA. HsiehSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform3/7/2025Morgan Stanley3 of 5 starsJeffrey HungSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight$5.00+10.50%12/9/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$42.00 ➝ $7.00-65.16%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:57 PM ET. BIOA Forecast - Frequently Asked Questions What is (BIOA)'s forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for (BIOA) is $5.67, with a high forecast of $7.00 and a low forecast of $5.00. Should I buy or sell (BIOA) stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for (BIOA) in the last year. There is currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" BIOA shares. Does (BIOA)'s stock price have much upside? According to analysts, (BIOA)'s stock has a predicted upside of 34.28% based on their 12-month stock forecasts. What analysts cover (BIOA)? (BIOA) has been rated by research analysts at Citigroup, Morgan Stanley, and William Blair in the past 90 days. Do Wall Street analysts like (BIOA) more than its competitors? Analysts like (BIOA) less than other "medical" companies. The consensus rating for (BIOA) is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BIOA compares to other companies. Stock Forecasts and Research Tools Related Companies ANAB Stock Forecast XERS Stock Forecast ABUS Stock Forecast ARVN Stock Forecast KALV Stock Forecast TRVI Stock Forecast KROS Stock Forecast PHAR Stock Forecast CAPR Stock Forecast ORGO Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:BIOA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIOA Stock Free BIOA Stock Alerts